Corrigendum to "A narrative review of approved and emerging anti-obesity medications" [Saudi Pharm. J. 31(10) (2023) 101757].

Beshir, Semira Abdi; Elnour, Asim Ahmed; Soorya, Aadith; Mohamed, Affana Parveen; Goh, Sheron Sir Loon; Hussain, Nadia; Al Haddad, Amal H I; Hussain, Faizah; El Khidir, Israa Yousif; Abdelnassir, Zainab.

Afiliação

Beshir SA; Department of clinical pharmacy and Pharmacotherapeutics, Dubai Pharmacy College For Girls, Dubai, United Arab Emirates.
Elnour AA; Program of Clinical Pharmacy, College of Pharmacy, Al Ain University, Abu Dhabi Campus, United Arab Emirates.
Soorya A; AAU Health and Biomedical Research Centre, Al Ain University, Abu Dhabi, United Arab Emirates.
Mohamed AP; College of Medicine, Gulf Medical University, Ajman, United Arab Emirates.
Goh SSL; College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.
Hussain N; Department of Primary Care Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Al Haddad AHI; Department of Pharmaceutical Sciences, College of Pharmacy, 105949, Al Ain University, Al Ain, United Arab Emirates.
Hussain F; AAU Health and Biomedical Research Center, Al Ain University, Abu Dhabi, United Arab Emirates.
El Khidir IY; Chief Operation Officer, Sheikh Shakhbout Medical City (SSMC), Abu Dhabi, United Arab Emirates.
Abdelnassir Z; Department of clinical pharmacy and Therapeutics, Dubai Pharmacy College, Dubai, United Arab Emirates.

Saudi Pharm J ; 32(5): 102047, 2024 May.

Article em En | MEDLINE | ID: mdl-38596318

ABSTRACT

[This corrects the article DOI 10.1016/j.jsps.2023.101757.].

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article